Loading...
Docetaxel for hormone-naive prostate cancer (PCa): Results from long-term follow-up of non-metastatic (M0) patients in the STAMPEDE randomised trial
James, ND Ingleby, FC Amos, C Attard, G Cross, W Dearnaley, D Gilbert, D Jones, R Langley, R
James, ND
Ingleby, FC
Amos, C
Attard, G
Cross, W
Dearnaley, D
Gilbert, D
Jones, R
Langley, R
Citations
Altmetric:
Abstract
Description
Date
2019
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
James ND, Ingleby FC, Clarke NW, Amos C, Attard G, Cross W, et al. 855PD Docetaxel for hormone-naïve prostate cancer (PCa): Results from long-term follow-up of non-metastatic (M0) patients in the STAMPEDE randomised trial. Annals of Oncology. 2019;30(Supplement_5).